SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012548
Filing Date
2019-08-14
Accepted
2019-08-14 16:21:36
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 673394
2 ex31-1.htm EX-31.1 20668
3 ex32-1.htm EX-32.1 8872
  Complete submission text file 0001493152-19-012548.txt   3980413

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE aker-20190630.xml EX-101.INS 641947
5 XBRL SCHEMA FILE aker-20190630.xsd EX-101.SCH 70976
6 XBRL CALCULATION FILE aker-20190630_cal.xml EX-101.CAL 54981
7 XBRL DEFINITION FILE aker-20190630_def.xml EX-101.DEF 180471
8 XBRL LABEL FILE aker-20190630_lab.xml EX-101.LAB 450693
9 XBRL PRESENTATION FILE aker-20190630_pre.xml EX-101.PRE 280844
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 191026723
SIC: 2835 In Vitro & In Vivo Diagnostic Substances